Türk Karaciğer Araştırmaları Derneği

Jeffrey V. LAZARUS, MD

Professor of CUNY Graduate School of Public Health and Health Policy (CUNY SPH).
Research Professor of Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona.
Associate Professor at the Faculty of Medicine, University of Barcelona.
International Health

He leads the Healthy Liver, Healthy Lives collaboration (AASLD, ALEH, APASL, EASL), which in 2023 published global NAFLD research and action priorities, and is a member of the Public Health and Policy Committee of the European Association for the Study of the Liver. He is co-chair of Innovations in NAFLD Care Workshop (INCBCN) and in 2023 co-chair of the EASL SLD Summit. In 2019, he joined the Lancet GastroHep Commission on Viral Hepatitis and the EASL-Lancet Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality. Prof Lazarus led the global NAFLD public health consensus statement, the expert recommendation on NAFLD models of care and the methodology for the new fatty liver disease nomenclature. Previously, he worked for 11 years at WHO Europe and 3 at the Global Fund as well as founding director of Health Systems Global and board chair of the foundation AFEW International.